Document headings vary by document type but may contain
                    the following: the agency or agencies that issued and signed a document
the number of the CFR title and the number of each part
                      the document amends, proposes to amend, or is directly
                      related to
the agency docket number / agency internal file number
the RIN which identifies each regulatory action listed in
                      the Unified Agenda of Federal Regulatory and Deregulatory
                      Actions See the
                    Document Drafting Handbook
                    for more details.
 Department of Health and Human Services Centers for Disease Control and Prevention [30Day-09-05CS]
 The Centers for Disease Control and Prevention (CDC) publishes a list of information collection requests under review by the Office of Management and Budget (OMB) in compliance with the Paperwork Reduction Act (44 U.S.C. Chapter 35). To request a copy of these requests, call the CDC Reports Clearance Officer at (404) 639-5960 or send an e-mail to 
                    *omb@cdc.gov*. Send written comments to CDC Desk Officer, Office of Management and Budget, Washington, DC or by fax to (202) 395-6974. Written comments should be received within 30 days of this notice. Proposed Project Nurse Delivered Risk Reduction Intervention for HIV-Positive Women—New—National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention (CDC). Background and Brief Description During the past two decades, HIV surveillance data indicates an increase in HIV/AIDS cases among women in the non-urban Southeastern United States. In 2006, the majority of HIV/AIDS cases (80%) among women were attributed to high-risk heterosexual contact with an infected partner. Black women in particular have been disproportionately impacted by HIV/AIDS. Factors shown to be associated with HIV in the South include poverty, lack of access to medical care, poor education, lack of awareness of the disease, and exposure to other sexually transmitted diseases. Presently, there is an urgent need for enhanced HIV transmission prevention interventions for HIV positive women in the southeastern United States. The purpose of this project is to adapt and test the efficacy of an HIV transmission prevention intervention for reducing sexual risk among 330 HIV-positive women in North Carolina and to identify factors associated with risk among women. The study will be conducted in two parts (intervention trial and individual in-depth interviews). The intervention trial will evaluate a brief, nurse delivered, single session intervention. The trial will use a randomized wait-list comparison design with a three-month follow-up assessment. To determine eligibility for participation in the study, a brief, in-person, screening will be used. Eligible participants will complete baseline and follow-up behavioral assessments. The assessments contain questions about participants' background, health and health care, sexual activity, substance use, and other psychosocial issues. The in-depth interviews will be conducted with a subgroup of 25-30 women. The purpose of the in-depth interviews is to assess experiences with the intervention, elicit recommendations for developing risk reduction intervention strategies, and to better understand the factors that place women at risk for HIV. Study participants will be recruited from health departments and clinics providing healthcare to HIV-positive women and AIDS Service Organizations. There is no cost to the participants other than their time. The total estimated annual burden hours are 635. Estimated Annualized Burden Hours
Type of respondents
Form name
Number of
                             respondents
Number of
                             responses per respondent
Avg. burden
                             per response 
                             (in hours)Potential Participants
Screener Contact Form
550
1
10/60Intervention Participants—and Comparison Group)
Locator Form
330
1
3/60Intervention Participants—and Comparison Group
Assessment Baseline
330
1
45/60Intervention Participants—and Comparison Group
Assessment Follow-up
330
1
45/60Subset of Intervention Group
In-depth Interview
30
1
1
 Dated: May 26, 2009. Maryam I. Daneshvar, Acting Reports Clearance Officer, Centers for Disease Control and Prevention.


[FR Doc. E9-12622 Filed 5-29-09; 8:45 am] BILLING CODE 4163-18-P